Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only

Home/AK/Anchorage

Updated October 2026 from ClinicalTrials.gov

Paid Clinical Trials in Anchorage, AK

Studies commonly pay $75 to $4,500 per completed study

112 clinical trials are currently recruiting participants within 30 miles of Anchorage. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

112studies recruiting

1+research centers nearby

4condition categories

Live from the NIH registry

Studies recruiting near Anchorage right now

Top 25 of 112 recruiting studies, sorted by proximity — each links to its official registry page

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Breast Cancer Phase 3 Interventional 3,960 participants sought

Anchorage Associates in Radiation Medicine — Anchorage, Alaska (26.8 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT05879926)

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

Heart Failure Phase 3 Interventional 11,300 participants sought

Research Site — Anchorage, Alaska (26.8 mi) · Sponsor: AstraZeneca

See eligibility & contact on ClinicalTrials.gov (NCT06677060)

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Phase 3 Interventional 247 participants sought

Anchorage Associates in Radiation Medicine — Anchorage, Alaska (26.8 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT04269902)

Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure

Healthy Adult Participants N/A Observational 15 participants sought

Decentralized / At-Home Participation (U.S.) — Anchorage, Alaska (26.8 mi) · Sponsor: Ecotera Health LLC

See eligibility & contact on ClinicalTrials.gov (NCT07775495)

Testing the Investigational Agent Combination of Daratumumab, Bortezomib, and Dexamethasone Compared to the Usual Treatment of Cyclophosphamide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients With Kidney Failure

Myeloma Multiple Phase 2 Interventional 74 participants sought

Alaska Oncology and Hematology LLC — Anchorage, Alaska (26.8 mi) · Sponsor: Eastern Cooperative Oncology Group

See eligibility & contact on ClinicalTrials.gov (NCT07085728)

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor Phase 2 Interventional 256 participants sought

Providence Alaska Medical Center — Anchorage, Alaska (26.8 mi) · Sponsor: Children's Oncology Group

See eligibility & contact on ClinicalTrials.gov (NCT04322318)

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

Breast Cancer N/A Observational 1,800 participants sought

Katmai Oncology Group - Anchorage — Anchorage, Alaska (26.8 mi) · Sponsor: Exact Sciences Corporation

See eligibility & contact on ClinicalTrials.gov (NCT06401421)

Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer

Miscellaneous Neoplasm, Nos, Non-Neoplastic Condition, Nos N/A Interventional 535 participants sought

Anchorage Associates in Radiation Medicine — Anchorage, Alaska (26.8 mi) · Sponsor: Alliance for Clinical Trials in Oncology

See eligibility & contact on ClinicalTrials.gov (NCT07091617)

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma Phase 3 Interventional 1,524 participants sought

Providence Alaska Medical Center — Anchorage, Alaska (26.8 mi) · Sponsor: Alliance for Clinical Trials in Oncology

See eligibility & contact on ClinicalTrials.gov (NCT07200830)

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

HER2-positive Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Phase 3 Interventional 840 participants sought

Research Site — Anchorage, Alaska (26.8 mi) · Sponsor: AstraZeneca

See eligibility & contact on ClinicalTrials.gov (NCT06764875)

Project: Every Child for Younger Patients With Cancer

Adrenal Gland Pheochromocytoma, Carcinoma In Situ N/A Observational 75,000 participants sought

Providence Alaska Medical Center — Anchorage, Alaska (26.8 mi) · Sponsor: Children's Oncology Group

See eligibility & contact on ClinicalTrials.gov (NCT02402244)

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma Phase 3 Interventional 360 participants sought

Alaska Women's Cancer Care — Anchorage, Alaska (26.8 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT05256225)

Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer

Extensive Stage Small Cell Lung Cancer (ES-SCLC) Phase 3 Interventional 695 participants sought

Alaska Oncology and Hematology — Anchorage, Alaska (26.8 mi) · Sponsor: Gilead Sciences

See eligibility & contact on ClinicalTrials.gov (NCT06801834)

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Plasma Cell Myeloma Phase 3 Interventional 510 participants sought

Anchorage Associates in Radiation Medicine — Anchorage, Alaska (26.8 mi) · Sponsor: SWOG Cancer Research Network

See eligibility & contact on ClinicalTrials.gov (NCT05561387)

School Screening and Telemedicine Specialty Referral to Address Childhood Hearing Loss in Rural Alaska

Hearing Loss N/A Interventional 8,060 participants sought

Southcentral Foundation — Anchorage, Alaska (26.8 mi) · Sponsor: University of Arkansas

See eligibility & contact on ClinicalTrials.gov (NCT05593484)

Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma

Pleural Biphasic Mesothelioma, Pleural Sarcomatoid Mesothelioma Phase 2 Interventional 26 participants sought

Anchorage Associates in Radiation Medicine — Anchorage, Alaska (26.8 mi) · Sponsor: Alliance for Clinical Trials in Oncology

See eligibility & contact on ClinicalTrials.gov (NCT05647265)

Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer

Refractory Differentiated Thyroid Gland Carcinoma Phase 3 Interventional 264 participants sought

Anchorage Associates in Radiation Medicine — Anchorage, Alaska (26.8 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

See eligibility & contact on ClinicalTrials.gov (NCT06475989)

Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia

Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma Phase 2 Interventional 80 participants sought

Providence Alaska Medical Center — Anchorage, Alaska (26.8 mi) · Sponsor: Children's Oncology Group

See eligibility & contact on ClinicalTrials.gov (NCT02981628)

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 Phase 3 Interventional 2,400 participants sought

Anchorage Associates in Radiation Medicine — Anchorage, Alaska (26.8 mi) · Sponsor: SWOG Cancer Research Network

See eligibility & contact on ClinicalTrials.gov (NCT05929768)

Group Music Therapy for Chronic Pain Management in Active Duty Service Members

Chronic Pain Phase 2 Interventional 130 participants sought

Joint Base Elmendorf-Richardson (JBER) — Anchorage, Alaska (26.8 mi) · Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine

See eligibility & contact on ClinicalTrials.gov (NCT07755540)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma Phase 3 Interventional 1,210 participants sought

Anchorage Associates in Radiation Medicine — Anchorage, Alaska (26.8 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT04267848)

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia Phase 2 Interventional 461 participants sought

Providence Alaska Medical Center — Anchorage, Alaska (26.8 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT04546399)

A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)

Non-small Cell Lung Cancer Phase 3 Interventional 868 participants sought

Alaska Oncology and Hematology ( Site 0039) — Anchorage, Alaska (26.8 mi) · Sponsor: Merck Sharp & Dohme LLC

See eligibility & contact on ClinicalTrials.gov (NCT06077760)

More Outside Your Door: a Diet/physical Activity Intervention to Decrease Risk of Obesity in Alaska Native Preschoolers

Child Obesity N/A Interventional 450 participants sought

Alaska Native Tribal Health Consortium — Anchorage, Alaska (26.8 mi) · Sponsor: Alaska Native Tribal Health Consortium

See eligibility & contact on ClinicalTrials.gov (NCT06303544)

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Non-Small Cell Lung Cancer Phase 3 Interventional 675 participants sought

Research Site — Anchorage, Alaska (26.8 mi) · Sponsor: AstraZeneca

See eligibility & contact on ClinicalTrials.gov (NCT06357533)

Actively enrolling

Studies you may be able to join near Anchorage

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Google-rated

Top-rated research centers in Anchorage

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Aurora Clinical Research

9500 Independence Dr, Anchorage, AK 99507

(907) 759-7559

Website

Clinical trials in Anchorage: what's recruiting

The Anchorage area currently has 112 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Anchorage, the most active research areas are:

Cancer & Oncology19 studies
Liver & Kidney2 studies
Heart & Vascular1 studies
Diabetes & Metabolism1 studies

Every listing shows the study phase, the recruiting site and its distance from Anchorage, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Anchorage

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Anchorage participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Anchorage?

No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.

Are clinical trials in Anchorage safe?

Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.

Is compensation for clinical trials taxable?

In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.

How often do new paid studies open in Anchorage?

Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Anchorage.

Can I be in more than one clinical trial at a time?

Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Anchorage typically complete one or two studies per year.

Paid clinical trials near Anchorage

Other metros within reach

Bremerton, WA1,475 Olympia, WA229 Marysville, WA200 Seattle, WA1,503 Tacoma, WA1,454 Bellevue, WA1,510 Vancouver, WA1,031 Salem, OR111

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts